Pharmista Technologies ApS: Financial statements 2024
CVR: 44617072
Source: annual report 2024, Danish Business Authority
05/02/2024 – 31/12/2024
Pharmista Technologies ApS (CVR 44617072) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,599,559 and a net result of DKK -1,701,491. Equity in the 2024 report amounted to DKK -1,661,491.
- Gross Profit
- DKK -1,599,559
- Profit/Loss
- DKK -1,701,491
- Equity
- DKK -1,661,491
- Total Assets
- DKK 2,434,528
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of February 5, 2024, Alice Anna Lovisa Mattsson is registered as director of Pharmista Technologies ApS.
As of February 5, 2024, is registered as an owner of Pharmista Technologies ApS with an ownership share of 100%.
Pharmista Technologies ApS was founded on February 5, 2024.
About Pharmista Technologies ApS
Pharmista Technologies ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2024. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rasmus Lindsten. The company is owned by Pharmista Technologies AB. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,810,297 and a net result of DKK -1,929,197 compared with DKK -1,701,491 the year before. Equity in the 2025 report amounted to DKK -3,590,689.